Moexipril Articles
US FDA approves Teva's generic Uniretic
19 March 2007
Schwarz Pharma's revenue up 4.6% in 2005
27 February 2006
Schwartz Pharma boosted by US sales
9 May 2005
Schwarz Pharma wins Univasc case
17 January 2005
Teva's generic Univasc cleared in USA
19 May 2003
Schwarz Pharma looks to have turned corner
12 November 2001
Schwarz Pharma net income up 65% as operating loss narrows
21 February 2001
NCEs In 1995: A Good Range Of Novel Drugs
29 January 1996
Moexipril Takes On Other ACEIs On Price
29 January 1996
US FDA Approving Fewer NMEs, But Faster, In 1995
11 September 1995
Schwarz' Univasc Cheapest ACE Inhibitor?
17 July 1995
Schwartz Pharma; Univasc
22 May 1995
MOEX "APPROVABLE"
8 August 1994
SCHWARTZ RECEIVES APPROVABLE LETTER
30 May 1994
Showing 1-16 of 16 articles
- 1
- Encouraging results with Sangamo's SB-728-T in HIV treatment
- Bristol-Myers' data on Yervoy and nivolumab causes a stir
- Boehringer Ingelheim transitions to propellant-free Combivent Respimat; names new BMD member
- Sanofi prepares for regulatory filing of MF candidate on positive JAKARTA study results
- Neovacs moving forward in rheumatoid arthritis, say analysts
